Aigen Investment Management LP Invests $27,000 in Varian Medical Systems, Inc. (NYSE:VAR)

Aigen Investment Management LP bought a new position in Varian Medical Systems, Inc. (NYSE:VAR) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 156 shares of the medical equipment provider’s stock, valued at approximately $27,000.

Several other hedge funds also recently bought and sold shares of VAR. Ovata Capital Management Ltd bought a new position in shares of Varian Medical Systems in the second quarter worth about $25,000. FNY Investment Advisers LLC bought a new position in shares of Varian Medical Systems in the third quarter worth about $27,000. SRS Capital Advisors Inc. bought a new position in shares of Varian Medical Systems in the second quarter worth about $29,000. CWM LLC lifted its holdings in shares of Varian Medical Systems by 76.1% in the third quarter. CWM LLC now owns 199 shares of the medical equipment provider’s stock worth $34,000 after acquiring an additional 86 shares during the last quarter. Finally, Valeo Financial Advisors LLC lifted its holdings in shares of Varian Medical Systems by 208.8% in the second quarter. Valeo Financial Advisors LLC now owns 315 shares of the medical equipment provider’s stock worth $39,000 after acquiring an additional 213 shares during the last quarter. 92.32% of the stock is owned by hedge funds and other institutional investors.

In other news, insider Kolleen T. Kennedy sold 400 shares of the firm’s stock in a transaction that occurred on Monday, September 14th. The shares were sold at an average price of $173.48, for a total transaction of $69,392.00. Following the completion of the sale, the insider now owns 27,518 shares of the company’s stock, valued at approximately $4,773,822.64. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Kolleen T. Kennedy sold 543 shares of the firm’s stock in a transaction that occurred on Tuesday, September 8th. The stock was sold at an average price of $173.60, for a total transaction of $94,264.80. Following the sale, the insider now directly owns 27,661 shares of the company’s stock, valued at approximately $4,801,949.60. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 2,286 shares of company stock valued at $395,288. Insiders own 0.78% of the company’s stock.

NYSE:VAR opened at $173.51 on Friday. The company has a market capitalization of $15.78 billion, a PE ratio of 56.52 and a beta of 1.16. The company has a 50 day simple moving average of $172.59 and a two-hundred day simple moving average of $149.79. Varian Medical Systems, Inc. has a fifty-two week low of $89.62 and a fifty-two week high of $176.19.

Varian Medical Systems (NYSE:VAR) last announced its quarterly earnings data on Tuesday, October 27th. The medical equipment provider reported $1.12 EPS for the quarter, topping the consensus estimate of $0.98 by $0.14. Varian Medical Systems had a net margin of 8.82% and a return on equity of 19.68%. During the same quarter in the prior year, the business posted $1.21 earnings per share. As a group, research analysts expect that Varian Medical Systems, Inc. will post 3.77 EPS for the current fiscal year.

VAR has been the subject of several recent research reports. Robert W. Baird downgraded Varian Medical Systems from an “outperform” rating to a “neutral” rating and set a $178.00 price objective for the company. in a research note on Wednesday, October 28th. Piper Sandler downgraded Varian Medical Systems from an “overweight” rating to a “neutral” rating and upped their price objective for the company from $142.00 to $177.50 in a research note on Sunday, August 2nd. Jefferies Financial Group upped their price objective on Varian Medical Systems from $130.00 to $178.00 and gave the company a “buy” rating in a research note on Monday, August 3rd. UBS Group downgraded Varian Medical Systems to an “in-line” rating in a research note on Tuesday, November 17th. Finally, BTIG Research downgraded Varian Medical Systems from a “buy” rating to a “neutral” rating in a research note on Monday, August 10th. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and one has given a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $145.55.

Varian Medical Systems Profile

Varian Medical Systems, Inc designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates in Oncology Systems and Proton Solutions segments. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as quality assurance equipment.

Further Reading: Pattern Day Trader – What is the PDT Rule?

Want to see what other hedge funds are holding VAR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varian Medical Systems, Inc. (NYSE:VAR).

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.